The role of hyperleptinaemia and low values of interleukin 10 in de novo DSA production after kidney transplantation

被引:0
|
作者
Dedinska, Ivana [1 ,2 ,3 ,5 ]
Kleinova, Patricia [1 ,2 ,3 ]
Machalekova, Katarina [4 ]
Granak, Karol [1 ,2 ,3 ]
Vnucak, Matej [1 ,2 ,3 ]
Beliancinova, Monika [1 ,2 ,3 ]
机构
[1] Univ Hosp Martin, Transplant Ctr, Martin, Slovakia
[2] Comenius Univ, Jessenius Fac Med, Bratislava, Slovakia
[3] Univ Hosp Martin, Dept Internal Dis 1, Martin, Slovakia
[4] St Elizabeth Canc Inst, Dept Pathol, Bratislava, Slovakia
[5] Univ Hosp Martin, Transplant Ctr, Kollarova 2, Martin 03601, Slovakia
关键词
Leptin; IL-10; Protocol biopsy; Kidney transplantation; LEPTIN LEVELS; BODY-FAT; POLYMORPHISMS; ADIPONECTIN; ACTIVATION; DISEASE; WEIGHT; IL-10; ALPHA; INDEX;
D O I
10.1016/j.trim.2023.101982
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: White adipose tissue secretes a number of peptide hormones. The aim of this paper was to determine the role of leptin, adiponectin and interleukin-10 and interleukin-6 on the development of graft rejection in protocol biopsy after kidney transplantation. Methods: In a prospective analysis (n = 104), we monitored the values of leptin, adiponectin, IL -6, and IL -10 prior to the transplantation and in the 3rd month after the transplantation. The protocol biopsy of the graft was performed in the 3rd month after the transplantation. The group was divided into the following according to the biopsy result: negative result, IFTA 1, borderline, and DSA positive. Results: After adjusting for the differences in the baseline recipient and donor characteristics, we identified the hyperleptinaemia baseline (HR = 2.0444, P = 0.0341) and month 3 (HR = 49.8043, P < 0.0001) as independent risk factors for borderline changes in the protocol biopsy. The hyperleptinaemia baseline (HR = 7.4979, P = 0.0071) and month 3 (HR = 9.7432, P = 0.0057) are independent risk factors for de novo DSA positivity. A low value of IL -10 month 3 is a risk factor for de novo DSA positivity (HR = 3.0746, P = 0.0388). Conclusions: Higher leptin levels and low values of IL -10 might play a role in rejection and de novo DSA production.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Treatment of De Novo DSA with IVIG Monotherapy After Lung Transplantation
    Castaneda, S. J.
    Girgis, R. E.
    Mietz, M. S.
    Lawson, C. K.
    McDermott, J. K.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S112 - S112
  • [22] Calcineurin Inhibitor Withdrawal is the Significant Risk Factor for De Novo DSA Production in Living Donor Kidney Transplantation
    Hiramitsu, T.
    Tomosugi, T.
    Futamura, K.
    Okada, M.
    Goto, N.
    Narumi, S.
    Uchida, K.
    Watarai, Y.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 849 - 850
  • [23] DE NOVO MULTIPLE MYELOMA AFTER KIDNEY TRANSPLANTATION
    Safadi, Sami
    Leung, Nelson
    Cosio, Fernando
    Amer, Hatem
    Gertz, Morie
    Rajkumar, Vincent
    Hayman, Suzanee
    Lacy, Martha
    Dispenzieri, Angela
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2014, 63 (05) : A96 - A96
  • [24] De novo diabetes complications after kidney transplantation
    Burroughs, TE
    Lentine, KL
    Irish, WD
    Brennan, DC
    Schnitzler, MA
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 409 - 409
  • [25] Recurrent and de novo Glomerulonephritis After Kidney Transplantation
    Lim, Wai H.
    Shingde, Meena
    Wong, Germaine
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [26] Early De Novo malignancies after kidney transplantation
    Veroux, M
    Puliatti, C
    Fiamingo, P
    Cappello, D
    Macarone, M
    Puliatti, D
    Vizcarra, I
    Gagliano, M
    Veroux, P
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (03) : 718 - 720
  • [27] ECULIZUMAB FOR DE NOVO HUS AFTER KIDNEY TRANSPLANTATION
    Kocak, Burak
    Akyollu, Basak
    Karatas, Cihan
    AkiNci, Serkan
    Arpali, Emre
    Yelken, Berna
    Gorcin, Serpil
    Demiralp, Emel
    Turkmen, AydiN
    TRANSPLANT INTERNATIONAL, 2015, 28 : 247 - 247
  • [28] De Novo Urological Malignancies after Kidney Transplantation
    Karczewski, M. R.
    Karczewski, J. Z.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 202 - 203
  • [29] De novo thrombotic microangiopathy after kidney transplantation
    Garg, Neetika
    Rennke, Helmut G.
    Pavlakis, Martha
    Zandi-Nejad, Kambiz
    TRANSPLANTATION REVIEWS, 2018, 32 (01) : 58 - 68
  • [30] Inflammatory Events Precede Development of De Novo DSA after Lung Transplantation
    Ponor, I. L.
    Jackson, A.
    Cochrane, A.
    Tunc, I.
    Jang, M.
    Mathew, J.
    D'Emilio, N.
    Luikart, H. I.
    Timofte, I.
    Brown, A.
    Shah, P.
    Nathan, S.
    Iacono, A.
    Orens, J. B.
    Marboe, C.
    Berry, G. J.
    Khush, K.
    Valantine, H.
    Agbor-Enoh, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S145 - S146